Resmed RMD has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart Comfort. The company will debut Smart Comfort in early 2026 in a limited U.S.
DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 70,000 newsletter subscribers for 21 days.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果